RA0794

antibody from Oursmab
Targeting: TNFSF4 CD252, gp34, OX-40L, TXGP1
Provider product page for RA0794
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0794 - Provider product page
Provider
Oursmab
Product name
Amlitelimab (Biosimilar Reference Antibody) (TNFSF4)
Antibody type
Monoclonal
Description
Amlitelimab (KY1005) is a fully human monoclonal antibody that targets OX40 ligand (OX40L; also known as CD252). It functions as a blocking antibody that inhibits the interaction between OX40L and its receptor OX40 (CD134). By disrupting this key co-stimulatory pathway, amlitelimab modulates T cell activation and function, aiming to dampen the pathological immune response in inflammatory diseases. It is currently being investigated in clinical trials as a potential treatment for atopic dermatitis.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
TNFSF4 protein structure - RA0794 shown in red.